The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (248)
- Medicine safety (159)
- COVID-19 (144)
- Prescription medicines (139)
- Regulatory compliance (128)
- COVID-19 vaccines (88)
- Legislation (81)
- Therapeutic goods regulation (75)
- Listed medicines (54)
- Non-prescription medicines (50)
- Safety (49)
- Medical devices safety (43)
- Vaping hub (39)
- Complementary medicines (33)
- Manufacturing (33)
- Labelling and packaging (28)
- Assessed listed medicines (26)
- Over the counter (OTC) medicines (25)
- Scheduling (national classification system) (24)
- Australian Register of Therapeutic Goods (ARTG) (22)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Alert/Advisory (18)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (8)
- Weight loss products (8)
- Advisory bodies and committees (5)
- Clinical trials (3)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Biological medicines (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
1094 result(s) found, displaying 26 to 50
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NewsYour feedback is essential to shaping a user-friendly website that works better for everyone.
-
Media releasesWe have issued a combined total of $396,000 in infringement notices to 20 Melbourne retail businesses for the alleged unlawful supply of vaping goods.
-
Safety updatesAdditional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events.
-
NoticesThis consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989.
-
NoticesThis instrument is made under subsections 19(5AA), 32CM(1A) and 41HC(1A) of the Therapeutic Goods Act 1989.
-
Therapeutic Goods (Special Access Scheme - Application and Notification Forms) Approval (No. 2) 2024
NoticesThis instrument is made under the Therapeutic Goods Regulations 1990, the Therapeutic Goods (Medical Devices) Regulations 2002 and the Therapeutic Goods Act 1989. -
Media releasesThe defendant faces a maximum penalty of 12 months’ imprisonment and/or a fine of up to $222,000 for each charge.
-
NewsRecall reforms program update and preview of the PRAC Version 1.0.
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesThe TGA and cooperating agencies have seized a large volume of alleged illicit vapes, tobacco and other substances in coordinated operations across Australia.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NoticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
NewsFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
BlogWe know that paracetamol is safe and effective for most people when taken at the recommended dose.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
NewsWe have introduced new features to improve your experience using Guidance on our website.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
Media releasesThe TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA.
-
Media releasesIn a significant move against the illicit vaping market, the TGA has played a vital role in joint enforcement activity with Victoria Police, resulting in the seizure of 200,000 vapes, worth more than $8 million